Search results

Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
Pre-eclampsia and CVD
Author(s): Veronica Giorgione , Matthew Cauldwell , Basky Thilaganathan Added: 10 months ago

Demographic

Prevention & Chronic Conditions
The Fourth Trimester: Pregnancy as a Predictor of Cardiovascular Disease
Author(s): Pensée Wu , Ki Park , Martha Gulati Added: 2 years ago

Demographic
Author(s): Renata Cífková Added: 3 years ago
Hypertension is the most prevalent cardiovascular disease affecting 20–50 % of the adult population.1 Elevated blood pressure has been identified as a risk factor for coronary heart disease (CHD), heart failure, stroke, peripheral arterial disease, renal failure and atrial fibrillation both in men and women in a large number of epidemiological studies.2–4 So far, the largest meta-analysis of… View more

Anticoagulation

Prevention & Chronic Conditions
Ep 7: Socioeconomic Factors Impacting Coronary and Structural Intervention
Author(s): Natalia Berry , Renée Bullock-Palmer Added: 1 year ago
What are the social factors that impact access to coronary and structural intervention in the current landscape of cardiology? In this month's episode of ECR Podcast, guest editor of ECR's special focus on gender disparities in interventional and structural heart procedures, Dr Natalia Berry (Mid Atlantic Permanente Medical Group, Washington DC, USA) is joined by Dr Renee Bullock-Palmer, … View more

Demographic
TCT 2018: RADIOSOUND-HTN
Author(s): Philipp Lurz Added: 5 years ago
Dr Philipp Lurz (Leipzig Heart Center, Leipzig, DE) discusses RADIOSOUND-HTN - A three-arm randomised trial of different renal denervation devices and techniques in patients with resistant hypertension. Filmed by Radcliffe Cardiology on site TCT 2018. View more

Prevention & Chronic Conditions
Introduction to CV Health Concerns Among LGBTQ+ Populations
Author(s): Billy A Caceres , Carl Streed Added: 2 years ago
In this video Dr. Billy A. Caceres(Columbia University School of Nursing, US) meetsDr. Carl G. Streed (Boston University School of Medicine, Boston, MA, US) to give an introduction to the topic of cardiovascular health concerns among LGBTQ+ populations for healthcare professionals (including physicians, nurses, physician assistants) with expertise in primary care, cardiology, preventive… View more

Demographic

Standards & Guidelines
CV Risk Biomarkers in Women with Prior Preeclampsia/HELLP Syndrome
Author(s): Esmee ME Bovee , Martha Gulati , Angela Maas Added: 2 years ago

Demographic

MI/ACS
EuroPCR 22: Patient-Level Pooled Analysis of Ultrasound RDN in radiance-HTN SOLO & Trio
Author(s): Ajay J Kirtane Added: 1 year ago
In this short interview, Dr Ajay Kirtane (Columbia University Medical Center, US) shares the findings from a patient-level pooled analysis of Ultrasound RDN in radiance-HTN SOLO and Trio. The analysis presented at EuroPCR 22 showed reductions in blood pressure in both cohorts at 6 months. Discussion Points 1. Study Background 2. Study Design & Patient Selection Criteria 3. Key Results 4. Which… View more

Prevention & Chronic Conditions
Focus on Women's Health: Takeaways from ESC 2023
Author(s): Marta Cvijic Added: 7 months ago
ESC 23 — In this collaboration between Women as One and Radcliffe Cardiology, Dr Marta Cvijic (University Medical Centre Ljubljana, SI) is joined by Prof Julia Grapsa (Guy's and St Thomas' NHS Trust Hospitals, UK) to discuss the latest data on women's health from ESC 2023. In this video, they discuss the latest heart failure guidelines, the STEP-HFpEF trial, and the unmet need for more trials… View more

Demographic

Heart Failure
Cardio-oncology A-Z: Breast Cancer Treatment Related Cardiotoxicity With Dr Anne Blaes
Added: 1 year ago
In this video we invited Dr Anne Blaes, Associate Professor in the Division of Hematology and Oncology at the University of Minnesota, to summarise the topic of breast cancer treatment related cardiotoxicity. Dr Blaes is an active medical oncologist with a special interest in the late effects of cancer therapy. Discussion Points: 1. What are the main cancer treatments that cause this problem? 2… View more

Demographic

CV Disease in Special Populations